Collectively, Sun et al. have discovered a promising and extensive network of negative regulation with alternation oncogenes and tumor suppressors consisting of β-TRCP, REST, miR-214, and PTPN12, which inhibit RTKs to control cell proliferation, tumorigenesis, and survival. The gene discussed is BTRC; the disease is neoplasm.